Taipei, Taiwan

King-Chun Chang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Jiu-Long Industrial Co., Ltd., Other. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: King-Chun Chang. Retrieved from https://idiyas.com/inventor/king-chun-chang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:

goldMedal1 out of 1 
 
Jiu-Long Industrial Co., Ltd.
 patent
silverMedal1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: King-Chun Chang: Innovator in Transdermal Drug Delivery

Introduction

King-Chun Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of transdermal drug delivery systems. His innovative approach has led to the development of a unique microneedle technology that enhances the effectiveness of drug administration.

Latest Patents

King-Chun Chang holds 1 patent for his invention titled "Transdermal microneedle unit and transdermal microneedle drug delivery device having the same." This invention relates to a transdermal microneedle unit that consists of multiple stacked sheets, each featuring at least one through hole and barbules arranged around the hole's perimeter. The design allows for the creation of triangular pyramidal transdermal microneedles, which facilitate efficient drug delivery through the skin.

Career Highlights

Throughout his career, King-Chun Chang has worked with various companies, including Jiu-Long Industrial Co., Ltd. His experience in the industry has allowed him to refine his inventions and contribute to advancements in medical technology.

Collaborations

King-Chun Chang has collaborated with notable professionals in his field, including his coworker Jung-Tang Huang. These partnerships have fostered innovation and the sharing of ideas, further enhancing the development of transdermal drug delivery systems.

Conclusion

King-Chun Chang's work in transdermal drug delivery represents a significant advancement in medical technology. His innovative microneedle design has the potential to improve patient care and drug administration methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…